Cargando…

Biomedical Research and Corporate Interests: A Question of Academic Freedom

The current situation in medicine has been described as a crisis of credibility, as the profit motive of industry has taken control of clinical trials and the dissemination of data. Pharmaceutical companies maintain a stranglehold over the content of medical journals in three ways: (1) by ghostwriti...

Descripción completa

Detalles Bibliográficos
Autor principal: McHenry, Leemon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190547/
https://www.ncbi.nlm.nih.gov/pubmed/22013356
http://dx.doi.org/10.4103/0973-1229.37086
_version_ 1782213593381470208
author McHenry, Leemon
author_facet McHenry, Leemon
author_sort McHenry, Leemon
collection PubMed
description The current situation in medicine has been described as a crisis of credibility, as the profit motive of industry has taken control of clinical trials and the dissemination of data. Pharmaceutical companies maintain a stranglehold over the content of medical journals in three ways: (1) by ghostwriting articles that bias the results of clinical trials, (2) by the sheer economic power they exert on journals due to the purchase of drug advertisements and journal reprints, and (3) by the threat of legal action against those researchers who seek to correct the misrepresentation of study results. This paper argues that Karl Popper's critical rationalism provides a corrective to the failure of academic freedom in biomedical research.
format Online
Article
Text
id pubmed-3190547
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31905472011-10-19 Biomedical Research and Corporate Interests: A Question of Academic Freedom McHenry, Leemon Mens Sana Monogr Ethical Issues in Biomedicine The current situation in medicine has been described as a crisis of credibility, as the profit motive of industry has taken control of clinical trials and the dissemination of data. Pharmaceutical companies maintain a stranglehold over the content of medical journals in three ways: (1) by ghostwriting articles that bias the results of clinical trials, (2) by the sheer economic power they exert on journals due to the purchase of drug advertisements and journal reprints, and (3) by the threat of legal action against those researchers who seek to correct the misrepresentation of study results. This paper argues that Karl Popper's critical rationalism provides a corrective to the failure of academic freedom in biomedical research. Medknow Publications 2008 /pmc/articles/PMC3190547/ /pubmed/22013356 http://dx.doi.org/10.4103/0973-1229.37086 Text en © Mens Sana Monographs http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Ethical Issues in Biomedicine
McHenry, Leemon
Biomedical Research and Corporate Interests: A Question of Academic Freedom
title Biomedical Research and Corporate Interests: A Question of Academic Freedom
title_full Biomedical Research and Corporate Interests: A Question of Academic Freedom
title_fullStr Biomedical Research and Corporate Interests: A Question of Academic Freedom
title_full_unstemmed Biomedical Research and Corporate Interests: A Question of Academic Freedom
title_short Biomedical Research and Corporate Interests: A Question of Academic Freedom
title_sort biomedical research and corporate interests: a question of academic freedom
topic Ethical Issues in Biomedicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190547/
https://www.ncbi.nlm.nih.gov/pubmed/22013356
http://dx.doi.org/10.4103/0973-1229.37086
work_keys_str_mv AT mchenryleemon biomedicalresearchandcorporateinterestsaquestionofacademicfreedom